1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with p-aminohippuric acid in 1 studies
Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (p-aminohippuric acid) | Trials (p-aminohippuric acid) | Recent Studies (post-2010) (p-aminohippuric acid) |
---|---|---|---|---|---|
9,156 | 187 | 552 | 2,231 | 64 | 88 |
Protein | Taxonomy | 1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50) | p-aminohippuric acid (IC50) |
---|---|---|---|
Solute carrier family 22 member 6 | Homo sapiens (human) | 8.8 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brecht, HM; Haberstroh, U; Mihatsch, MJ; Oberle, G; Stahl, RA; Thaiss, F | 1 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and p-aminohippuric acid
Article | Year |
---|---|
Platelet-activating factor receptor antagonist improves renal function and glomerular lesions in renal ablation.
Topics: Albuminuria; Animals; Azepines; Blood Pressure; Body Weight; Eicosanoids; Inulin; Kidney; Kidney Glomerulus; Male; Nephrectomy; Organ Size; p-Aminohippuric Acid; Platelet Activating Factor; Rats; Rats, Wistar; Triazoles | 1994 |